Advertisement

Topics

FDA Okays Clinical Trial Testing of Psychedelic Drug for PTSD

13:00 EDT 30 Aug 2017 | Medscape

With input from the FDA and a new breakthrough therapy designation, phase 3 trials are set to begin for the psychedelic MDMA, also known as ecstasy, for assisted treatment of PTSD.
Medscape Medical News

Original Article: FDA Okays Clinical Trial Testing of Psychedelic Drug for PTSD

NEXT ARTICLE

More From BioPortfolio on "FDA Okays Clinical Trial Testing of Psychedelic Drug for PTSD"

Quick Search
Advertisement
 

Relevant Topic

Stress
Stress is caused by your perception of situations around you and then the reaction of your body to them. The automatic stress response to unexpected events is known as 'fight or flight'. Discovered by Walter Cannon in 1932, it is the release of h...